Our Services
Medical Information
Helpful Resources
Published on: 5/21/2026
Chronic sinusitis sustains inflammation through mediator spillover, postnasal drip, polyps, and biofilms, which worsens refractory asthma and reduces response to standard inhaled therapies. Treating sinus disease with nasal steroids, surgery, or biologic medications can often break this cycle and improve asthma control.
There are several important factors to consider in diagnosis and management; see below for full details on evaluations, advanced therapies, lifestyle measures, and urgent care indicators.
Chronic sinusitis and refractory asthma often go hand in hand. When sinus inflammation lingers for more than 12 weeks, it can feed ongoing airway problems that don't fully respond to standard asthma treatments. Understanding this link is key to finding relief.
Chronic sinusitis is a long-lasting inflammation of the sinus cavities around the nose. Common features include:
Unlike a simple cold, symptoms persist for at least three months. In some cases, nasal polyps or biofilms (bacterial "fortresses") contribute to ongoing inflammation.
Refractory asthma (also called severe or difficult-to-treat asthma) fails to improve despite high-dose inhaled steroids and other controller medications. Characteristics include:
Patients with refractory asthma often need additional therapies such as biologics or oral steroids.
Medical science increasingly views the upper and lower airways as one continuous system. Inflammation in the sinuses can:
This unified‐airway idea explains why chronic sinusitis and refractory asthma frequently coexist.
Inflammatory Spillover
Sinus inflammation releases chemicals (e.g., interleukins, leukotrienes) that circulate and amplify lung inflammation.
Postnasal Drip
Mucus dripping from inflamed sinuses irritates the bronchial tubes, leading to cough and bronchospasm (airway narrowing).
Biofilms and Bacterial Colonization
Bacterial biofilms in the sinuses resist antibiotics, allowing low-grade infections to smolder and worsen asthma control.
Nasal Polyps
Tissue growths in the nasal passages are linked to severe, eosinophil-driven inflammation, a pattern also seen in refractory asthma.
A thorough evaluation can reveal how sinusitis fuels difficult-to-treat asthma:
Addressing chronic sinusitis can unlock better asthma control. A combined approach typically includes:
Multiple studies show that patients with chronic sinusitis who undergo endoscopic sinus surgery often experience:
By clearing sinuses, surgery can break the cycle of inflammation that traps asthma in a refractory state.
If you suspect chronic sinusitis is fueling your hard-to-control asthma, get personalized insights by using a Medically approved LLM Symptom Checker Chat Bot to evaluate your symptoms and guide your next steps toward better respiratory health.
Always consult a healthcare provider if you experience:
These could be signs of a serious condition requiring urgent attention.
Managing chronic sinusitis and refractory asthma together offers the best chance for relief. By targeting the inflammation in your sinuses, you can often unlock better asthma control, reduce medication needs, and improve your daily life. Speak to your doctor about developing an integrated treatment plan tailored to your needs.
(References)
* P. A. G. C. J. R. H. C. A. M. H. F. J. P. L. T. J. H. F. Chronic Rhinosinusitis and Severe Asthma: A United Airway Perspective. J Allergy Clin Immunol Pract. 2021 May;9(5):1969-1976. doi: 10.1016/j.jaip.2020.12.052. Epub 2021 Jan 19. PMID: 33482434.
* B. C. V. Lehtimäki, A. B. C. P. Salo, J. V. K. Järvinen, P. M. F. Mattila, R. T. P. Backman, A. S. L. H. Nieminen, H. M. P. Seppänen, J. L. P. Kallio, S. K. A. Leivo, T. T. T. R. Virtanen. Impact of chronic rhinosinusitis with nasal polyps on asthma control and severity: a systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2022 Aug;129(2):162-172.e1. doi: 10.1016/j.anai.2022.04.020. Epub 2022 May 2. PMID: 35513076.
* M. N. J. Katelaris, D. E. W. J. R. A. C. B. H. M. B. J. M. C. J. C. K. K. M. L. L. R. L. R. P. B. L. B. M. L. R. N. S. O. P. S. A. S. C. S. A. W. C. Y. E. Z. M. H. R. J. R. D. D. C. Chronic Rhinosinusitis and Asthma: A Systematic Review and Meta-analysis. J Allergy Clin Immunol Pract. 2022 Feb;10(2):495-509.e16. doi: 10.1016/j.jaip.2021.09.043. Epub 2021 Oct 1. PMID: 34606990.
* D. M. T. T. C. E. L. A. J. S. P. P. C. Unified Airway Disease: The Upper Airway in Asthma. Front Pediatr. 2019 Sep 30;7:395. doi: 10.3389/fped.2019.00395. eCollection 2019. PMID: 31616654.
* A. E. H. T. L. M. V. M. P. S. E. L. C. V. S. C. L. R. P. M. T. L. T. Biologics in patients with severe asthma and chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2023 Jul;152(1):1-10. doi: 10.1016/j.jaci.2023.05.002. Epub 2023 May 10. PMID: 37172778.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.